Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Spur Therapeutics Logo
Spur Therapeutics Growth Score
81
CB Rank
30538
Heat Score
66
Spur Therapeutics is a clinical-stage biotechnology business dedicated to creating life-changing medicines for crippling chronic illnesses.
Acquired by
Ascend Gene & Cell Therapies Logo
Ascend Gene & Cell Therapies
Founded
obfuscation
PrivateFunding Round Stevenage, Herefordshire, United Kingdom101-250 spurtherapeutics.com
Analytics
Biotechnology
Health Care
Medical
Therapeutics
Overview

Spur Therapeutics
Total Funding
obfuscation
Growth Score
81
Heat Score
66

Total Funding
obfuscation
obfuscation
Funding Round raised
obfuscation
Growth Score81
-6 pts
in past quarter
Heat Score 66
-5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Spur Therapeutics

CB Rank
30538
Spur Therapeutics is a clinical-stage biotechnology business dedicated to creating life-changing medicines for crippling chronic illnesses.
Acquired by
Ascend Gene & Cell Therapies Logo
Ascend Gene & Cell Therapies
Founded
obfuscation
PrivateFunding Round Stevenage, Herefordshire, United Kingdom101-250 spurtherapeutics.com
Analytics
Biotechnology
Health Care
Medical
Therapeutics

Funding Rounds

Funding Round
OBF
in
obfuscation

Details

Sub-Organization of 
Freeline Logo
Freeline
Legal Name Freeline Therapeutics GmbH
Operating Status Active
Company Type For Profit
About the Company
Spur Therapeutics is a clinical-stage biotechnology business dedicated to creating life-changing medicines for crippling chronic illnesses.
Contact Email info@spurtherapeutics.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

FLT201
An AAV gene therapy candidate designed to deliver a longer-acting engineered GCase enzyme for treating Gaucher disease type 1 through a single intravenous dose.
avigbagene parvec (FLT201)
A gene therapy candidate designed to treat Gaucher disease type 1 by delivering an engineered GCase enzyme to liver cells to reduce toxic substrate buildup with a single infusion.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Funding Round - Spur Therapeutics Logo
Funding Round - Spur Therapeutics
1
obfuscation
Syncona Partners LLPFunding Round
obfuscation
Funding Round - Spur Therapeutics Logo
Funding Round - Spur Therapeutics
1
obfuscation
Syncona Partners LLPFunding Round
obfuscation
Funding Round - Spur Therapeutics Logo
Funding Round - Spur Therapeutics
1
obfuscation
Syncona Partners LLPFunding Round
obfuscation
Funding Round - Spur Therapeutics Logo
Funding Round - Spur Therapeutics
1
obfuscation
Syncona Partners LLPFunding Round
obfuscation
Funding Round - Spur Therapeutics Logo
Funding Round - Spur Therapeutics
1
obfuscation
Syncona Partners LLPFunding Round

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Funding Round - Spur Therapeutics Logo
Funding Round - Spur Therapeutics
1
obfuscation
Syncona Partners LLPFunding Round
obfuscation
Funding Round - Spur Therapeutics Logo
Funding Round - Spur Therapeutics
1
obfuscation
Syncona Partners LLPFunding Round
obfuscation
Funding Round - Spur Therapeutics Logo
Funding Round - Spur Therapeutics
1
obfuscation
Syncona Partners LLPFunding Round
obfuscation
Funding Round - Spur Therapeutics Logo
Funding Round - Spur Therapeutics
1
obfuscation
Syncona Partners LLPFunding Round
obfuscation
Funding Round - Spur Therapeutics Logo
Funding Round - Spur Therapeutics
1
obfuscation
Syncona Partners LLPFunding Round

Investors

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1

M&A Details

Spur Therapeutics was acquired by Ascend Gene & Cell Therapies for
obfuscation
on
obfuscation
.
Transaction Name 
Spur Therapeutics acquired by Ascend Gene & Cell Therapies Logo
Spur Therapeutics acquired by Ascend Gene & Cell Therapies
Acquired by 
Ascend Gene & Cell Therapies Logo
Ascend Gene & Cell Therapies
Announced Date 
obfuscation
Price 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 101-250 Board Members and Advisors 1 Contacts 98

Board Members and Advisors

News

News and Press

News•May 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 14, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

6,536
-41.73%
 in past month

Interest Signals

TopicSurge Score
English Language Arts (ELA) Educator Resources Logo
English Language Arts (ELA) Educator Resources
70
Research and Development / Test Logo
Research and Development / Test
66

Active Website Tech Count

29Spur Therapeutics is actively using 29 technologies for its website, according to BuiltWith. These include SSL by Default, HSTS, and  Euro.

Total IP

5The intellectual property of Spur Therapeutics includes 2 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery. Additionally, Spur Therapeutics has registered 3 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Spur Therapeutics's headquarters? Spur Therapeutics is located in Stevenage, Herefordshire, United Kingdom.Who invested in Spur Therapeutics? Spur Therapeutics is funded by Syncona Partners LLP.When was the last funding round for Spur Therapeutics? Spur Therapeutics closed its last funding round on
obfuscation
from a Undisclosed round.Who are Spur Therapeutics's competitors? Alternatives and possible competitors to Spur Therapeutics may include Asklepios BioPharmaceutical, BioMarin Pharmaceutical, and  Rocket Pharmaceuticals.How much funding has Spur Therapeutics raised to date? Spur Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|